Last Updated : December 13, 2018
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : September 16, 2019
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : May 3, 2019
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : July 5, 2019
Details
Key Milestones2 | |
|---|---|
| Call for patient input posted | November 22, 2018 |
| Patient group input closed | January 18, 2019 |
| Clarification: - Patient input submission received from Arthritis Consumer Experts and The Arthritis Society & Canadian Arthritis Patient Alliance | |
| Patient input summary sent for review to patient input groups | February 20, 2019 |
| Patient group comments on input summary closed | February 27, 2019 |
| Clarification: - Patient input summary feedback received | |
| Submission received | December 20, 2018 |
| Submission accepted for review | January 18, 2019 |
| Clarification: - Submission was not accepted for review on 11 Jan 2019 - Revised category 1 requirements received on 11 Jan 2019 | |
| Review initiated | January 30, 2019 |
| Clarification: - Submission temporarily suspended pending receipt of information - Additional information has been received and the temporary suspension of the review has been lifted | |
| Draft Canada's Drug Agency review report(s) sent to sponsor | April 29, 2019 |
| Comments from sponsor on draft Canada's Drug Agency review report(s) received | May 08, 2019 |
| Redaction requests from sponsor on draft Canada's Drug Agency review report(s) received | May 15, 2019 |
| Canada's Drug Agency review team's comments on draft Canada's Drug Agency review report(s) sent to sponsor | June 07, 2019 |
| Canadian Drug Expert Committee (CDEC) meeting | June 19, 2019 |
| CDEC recommendation & redacted Canada's Drug Agency review report(s) sent to sponsor and drug plans | July 02, 2019 |
| Embargo period ended and validation of redacted Canada's Drug Agency review report(s) received | July 26, 2019 |
| Clarification: - Request for extension to embargo period received from the manufacturer - Embargo extension request granted | |
| CDEC Final Recommendation issued to sponsor and drug plans | August 02, 2019 |
| CDEC Final Recommendation posted | August 07, 2019 |
| Final Canada's Drug Agency review report(s) posted | September 10, 2019 |
Last Updated : September 12, 2019
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : May 31, 2019
Details
Last Updated : November 19, 2018
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : August 19, 2019
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : August 19, 2019
Details
‡ Patient Advocacy Groups (or individual patients and caregivers when there is no patient group) and Clinicians who are registered with pCODR are eligible to provide Input and Feedback. Deadlines for Input and Feedback are by the end of the pCODR business day (5P.M. Eastern Time) of the date noted.
Last Updated : July 22, 2019